You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →
Polyphron raises $20M in seed financing led by Quiet Capital to build a physical verification layer for AI-driven biology.
PRIVATESep 17, 2026•about 3 hours ago
Amount Raised
$20 Million
Round Type
Seed
New YorkBiotechnologyArtificial IntelligenceMachine Learning
Investors
CompoundHaystackGradientQuiet Capital
Description
Polyphron, a company focused on building artificial human biology, has announced a $20M seed financing round. This funding will help them create a verification substrate for AI-driven biology. Participating investors include Gradient, Haystack, and Compound. The funding aims to transform drug development and treat disease through advanced AI systems.
Company Information
Company
Polyphron
Location
New York, New York, United States
About
Polyphron is a company building artificial human biology to transform drug development and treat disease. They train frontier AI models to manufacture and simulate living tissue. This approach creates the verification substrate for AI-driven biology. Their work is essential as AI systems become increasingly powerful in generating drug candidates and biological hypotheses.
Don't miss Polyphron's next move
Get an email the moment Polyphron raises, hires an exec, or expands, usually minutes after it happens.